Word

ICHNOS SCIENCES

Status

Dead

Status Code

606

Status Date

Monday, May 29, 2023

Serial Number

88449114

Mark Type

4000

Filing Date

Tuesday, May 28, 2019

Published for Opposition

Tuesday, March 3, 2020

Abandoned Date

Monday, May 29, 2023

Trademark Owner History

ICHNOS SCIENCES SA - 1st New Owner After Publication
Glenmark Pharmaceuticals Limited - Owner At Publication

Classifications

41 Educational services, namely, providing workshops and seminars in the fields of cancer treatment, oncology, immunology and pain management; Publication of journals featuring research articles and clinical trials for pharmaceutical preparations; education services, namely, conducting online instruction and courses in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; provision of educational content, namely, providing on-line instruction in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; training in the use and operation of medical devices, medical imaging apparatus and medical research apparatus and consultation relating thereto; educational services, namely, conducting live and online seminars, classes, workshops, lectures, panel discussions, and training programs in the field of pharmaceutical products, healthcare and medical diseases, disorders and related treatments; educational services, namely, providing non-downloadable webinars in the field of health and medical information and distribution of course material in connection therewith; education services, namely, developing, arranging and conducting educational programs and providing courses of instruction in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine; providing training programs and developing training programs relating to the use and operation of medical devices, medical research apparatus and consultation relating thereto; providing online publications, namely, instructional materials in the nature of worksheets and textbooks, featuring study materials in the field of pharmaceutical products, healthcare and medical disease, disorders and related treatments; conducting educational seminars in the fields of healthcare, the use of pharmaceuticals, and medical devices, medical research, surgery, medical science and medicine

5 Pharmaceutical preparations for human use for the treatment of respiratory disorders; nasal spray preparations; medical and pharmaceutical preparations, namely, inhaler preparations for treatment of Chronic obstructive pulmonary disease (COPD); Opium alkaloid preparations; pharmaceutical anti-allergic preparations and substances; pharmaceutical antitussive-cold preparations; pharmaceutical for the treatment of erectile dysfunction; pharmaceutical preparation for the treatment of gout; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for animal skincare; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for skin care; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, and for the treatment of inflammatory disorders, and for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in chemotherapy; pharmaceutical and biological preparations for the treatment of cancer; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for wounds; pharmaceutical preparations, namely, antidepressants; pharmaceutical preparations, namely, appetite suppressants; pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; pharmaceutical preparations, namely, anticoagulants; pharmaceutical products and preparations against dry skin caused by pregnancy; medicated skin care preparations; medicated skin care preparations, namely, gels; pharmaceutical products and preparations for chloasma; pharmaceutical products and preparations for hydrating the skin during pregnancy; pharmaceutical products and preparations for pregnancy blemishes; pharmaceutical products and preparations for preventing skin blemishes during pregnancy; pharmaceutical products and preparations to prevent stretch marks; pharmaceutical products and preparations to prevent swelling in the legs; pharmaceutical products for ophthalmological use; pharmaceutical products for skin care for animals; pharmaceutical products for the treatment of bone diseases; pharmaceutical products for the treatment of joint disease; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical products for treating respiratory diseases and asthma; pharmaceutical skin lotions; pharmaceutical solutions used in dialysis; pharmaceuticals for the treatment of erectile dysfunction; pharmaceuticals, namely, anti-infectives; pharmaceuticals, namely, antihelmintics; pharmaceuticals, namely, inducers of erections; pharmaceuticals, namely, lipid lowering agents; preparation for the relief of pain; preparations for the treatment of asthma; preparations for therapeutic or medical purposes, namely, therapeutic medicated skin preparations for treatment of skin diseases; decongestant nasal sprays

3 Cosmetic soaps; Skin soaps; shampoos; sunscreen for cosmetic use; perfumery; essential oils; body powder; cosmetics; anti-aging creams; hair lotion; cosmetic skin care preparations; skin creams; skin moisturizing gel; face wash; moisturizing body lotions; and non-medicated mouthwashes

35 Campaign for patient support program, namely, promoting public awareness for patients with cancer, pain management, skin care, management of diabetes, management of asthma, Chronic Obstructive Pulmonary Disease (COPD) and respiratory diseases

45 Licensing of patents, trademarks and intellectual property

44 Providing information in the field of medicine and health in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and dietetic advisory services; medical services in the field of oncology, pain management. dermatology, diabetology, respiratory diseases and dietetic advisory services; medical assistance in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and dietetic advisory services; hygiene care for human beings in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and dietetic advisory services; medical clinic services; dietetic advisory services; disseminating medical information to patients for better lifestyle management to handle the treatment of side effects in the course of treatment of cancer, pain management, skin care, management of diabetes, management of asthma, Chronic Obstructive Pulmonary Disease (COPD) and respiratory diseases

10 Medical apparatus and instruments, namely, spirometers; medical devices, namely, inhalers sold empty, nebulizers; medical devices, namely, autoanalysers; chromatographic medical diagnostic apparatus

42 Scientific research for medical purposes in the field of oncology, pain management, dermatology, diabetology, respiratory diseases, biosimilars; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological services, namely, scientific research, analysis, testing in the field of oncology, immunology and pain management; medical research in the fields of oncology, immunology and pain management; clinical research in the fields of oncology, immunology and pain management; scientific research and development; pharmaceutical drug development services; pharmaceutical research and development; research and development for new products for others; chemical, pharmaceutical, nutraceuticals and nutritional science, dermo-cosmetic and biotechnology analysis and research; design and testing for new product development; Diagnostic product testing and analysis, namely, medical research and product research for industrial uses; scientific research in the fields of chemistry, biotechnology and pharmacology; medical and pharmaceutical research services, scientific research services for medical purposes including and not limited to bacteriological research services, biomedical research services, laboratory research services, clinical trial services, pharmacological research services, medical research laboratory services, scientific and technological services and research and design relating thereto

"SCIENCES"

Trademark Events

May 30, 2023

Abandonment Notice E-Mailed - No Use Statement Filed

May 29, 2023

Abandonment - No Use Statement Filed

Sep 22, 2022

Notice Of Approval Of Extension Request E-Mailed

Sep 21, 2022

Sou Extension 5 Granted

Sep 8, 2022

Sou Extension 5 Filed

Sep 21, 2022

Case Assigned To Intent To Use Paralegal

Sep 8, 2022

Sou Teas Extension Received

Apr 16, 2022

Notice Of Approval Of Extension Request E-Mailed

Apr 14, 2022

Sou Extension 4 Granted

Apr 14, 2022

Sou Extension 4 Filed

Apr 14, 2022

Sou Teas Extension Received

Oct 28, 2021

Notice Of Approval Of Extension Request E-Mailed

Oct 26, 2021

Sou Extension 3 Granted

Oct 26, 2021

Sou Extension 3 Filed

Oct 26, 2021

Sou Teas Extension Received

Sep 7, 2021

Teas Change Of Correspondence Received

Sep 7, 2021

Teas Change Of Domestic Representatives Address

Sep 7, 2021

Attorney/Dom.Rep.Revoked And/Or Appointed

Sep 7, 2021

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Apr 29, 2021

Notice Of Approval Of Extension Request E-Mailed

Apr 27, 2021

Sou Extension 2 Granted

Apr 27, 2021

Sou Extension 2 Filed

Apr 27, 2021

Sou Teas Extension Received

Apr 14, 2021

Automatic Update Of Assignment Of Ownership

Oct 28, 2020

Notice Of Approval Of Extension Request E-Mailed

Oct 26, 2020

Sou Extension 1 Granted

Oct 26, 2020

Sou Extension 1 Filed

Oct 26, 2020

Sou Teas Extension Received

Apr 28, 2020

Noa E-Mailed - Sou Required From Applicant

Mar 3, 2020

Official Gazette Publication Confirmation E-Mailed

Mar 3, 2020

Published For Opposition

Feb 12, 2020

Notification Of Notice Of Publication E-Mailed

Jan 27, 2020

Assigned To Lie

Jan 24, 2020

Approved For Pub - Principal Register

Jan 24, 2020

Examiner's Amendment Entered

Jan 24, 2020

Notification Of Examiners Amendment E-Mailed

Jan 24, 2020

Examiners Amendment E-Mailed

Jan 24, 2020

Examiners Amendment -Written

Jan 14, 2020

Previous Allowance Count Withdrawn

Oct 8, 2019

Withdrawn From Pub - Og Review Query

Sep 19, 2019

Approved For Pub - Principal Register

Sep 19, 2019

Examiner's Amendment Entered

Sep 19, 2019

Notification Of Examiners Amendment E-Mailed

Sep 19, 2019

Examiners Amendment E-Mailed

Sep 19, 2019

Examiners Amendment -Written

Sep 17, 2019

Teas/Email Correspondence Entered

Sep 16, 2019

Correspondence Received In Law Office

Sep 16, 2019

Teas Response To Office Action Received

Sep 7, 2019

Combined Examiner's Amendment/Priority Action Entered

Sep 7, 2019

Assigned To Lie

Sep 6, 2019

Notification Of Examiner's Amendment/Priority Action E-Mailed

Sep 6, 2019

Examiner's Amendment/Priority Action E-Mailed

Sep 6, 2019

Examiners Amendment And/Or Priority Action - Completed

Aug 16, 2019

Assigned To Examiner

Jun 12, 2019

New Application Office Supplied Data Entered

May 31, 2019

New Application Entered